Diltiazem Hydrochloride Tablet, Extended Release
Product Images NDC 70436-199

Product Visual Gallery

This gallery contains 25 technical images submitted to the FDA as part of the official labeling for Diltiazem Hydrochloride (NDC 70436-199). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Slate Run Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

120mg-30ct (120mg 30ct)

Label for Diltiazem Hydrochloride Extended-Release Tablets 120 mg, an oral prescription medication. The label includes dosage strength, quantity of 30 tablets, and manufacturing details from Yichang Humanwell Oral Solid Dosage Plant in China, with distribution by Slate Run Pharmaceuticals, LLC in Columbus, Ohio. It also provides storage and safety warnings.*

FDA Label Image

120mg-90ct (120mg 90ct)

Label for Diltiazem Hydrochloride Extended-Release Tablets, 120 mg, by Slate Run Pharmaceuticals. The label states the product contains 90 tablets and includes usage and storage instructions, manufacturer and distributor information, and a barcode. It is designated Rx only.*

FDA Label Image

180mg-30ct (180mg 30ct)

The packaging label is for Diltiazem Hydrochloride Extended-Release Tablets, 180 mg strength, by Slate Run Pharmaceuticals, LLC. It indicates 30 tablets per bottle. The label includes dosage form as extended-release tablets for oral use, NDC 70436-196-04, and provides storage instructions, manufacturer and distributor information, as well as a child-resistant packaging notice.*

FDA Label Image

180mg-90ct (180mg 90ct)

Label for Diltiazem Hydrochloride Extended-Release Tablets, 180 mg, oral tablet dosage form. The label includes dosage information, storage instructions, and child-resistant packaging details. The product is manufactured by Yichang Humanwell Oral Solid Dosage Plant and distributed by Slate Run Pharmaceuticals, LLC. The package contains 90 tablets.*

FDA Label Image

240mg-30ct (240mg 30ct)

Label for Diltiazem Hydrochloride Extended-Release Tablets, 240 mg, oral tablet dosage form. The label shows the product name, strength, and quantity of 30 tablets. It lists Slate Run Pharmaceuticals, LLC as the labeler and includes storage instructions, child-safety warnings, and a barcode. The label features a section indicating "Coating free area for Exp. Lot and Serialization data."*

FDA Label Image

240mg-90ct (240mg 90ct)

Label for Diltiazem Hydrochloride Extended-Release Tablets, 240 mg strength, oral extended-release tablets. The label shows the NDC code 70436-197-06, the prescription-only designation, and a package size of 90 tablets. It is manufactured by Yichang Humanwell Oral Solid Dosage Plant in China and distributed by Slate Run Pharmaceuticals, LLC, Columbus, Ohio. Additional storage instructions and a barcode are also visible.*

FDA Label Image

300mg-30ct (300mg 30ct)

Label for Diltiazem Hydrochloride Extended-Release Tablets, 300 mg strength, oral extended-release tablets. The label indicates prescription use only and contains 30 tablets per package. Manufactured by Yichang Humanwell Oral Solid Dosage Plant and distributed by Slate Run Pharmaceuticals, LLC. The label includes storage instructions and a barcode.*

FDA Label Image

300mg-90ct (300mg 90ct)

Label for Diltiazem Hydrochloride Extended-Release Tablets, 300 mg oral tablets. The label shows the product name, strength, dosage form, a package size of 90 tablets, and the labeler Slate Run Pharmaceuticals, LLC. It includes dosing disclaimers, storage instructions, manufacturer details from Yichang Humanwell Oral Solid Dosage Plant in China, and a barcode. The label also mentions child-resistant packaging and a space for expiration and serialization data.*

FDA Label Image

360mg-30ct (360mg 30ct)

Label for Diltiazem Hydrochloride Extended-Release Tablets, 360 mg, by Slate Run Pharmaceuticals. The label shows a pack of 30 tablets with NDC 70436-199-04. It includes storage instructions, warnings, and manufacturer details from Yichang Humanwell Oral Solid Dosage Plant, Yichang, China, distributed by Slate Run Pharmaceuticals, Columbus, Ohio.*

FDA Label Image

360mg-90ct (360mg 90ct)

Label for Diltiazem Hydrochloride Extended-Release Tablets 360 mg by Slate Run Pharmaceuticals. The package contains 90 oral extended-release tablets. The label includes dosage strength, storage instructions, manufacturer and distributor information, and a barcode. The label emphasizes child-resistant packaging and controlled room temperature storage guidelines.*

FDA Label Image

420mg-30ct (420mg 30ct)

Diltiazem Hydrochloride Extended-Release Tablets 420 mg oral tablets label from Slate Run Pharmaceuticals, LLC. The label states 30 tablets per package, includes dosage form and strength, storage instructions, manufacturer and distributor information, barcode, and child-resistant packaging warnings.*

FDA Label Image

420mg-90ct (420mg 90ct)

Label for Diltiazem Hydrochloride Extended-Release Tablets, 420 mg, from Slate Run Pharmaceuticals. The label indicates 90 tablets in a child-resistant, light-resistant container, with storage instructions and manufacturer details in Yichang, China. It includes warnings, dosage guidance, and a barcode.*

FDA Label Image

A-1 (A 1)

Diltiazem Hydrochloride extended release tablets by Slate Run Pharmaceuticals, LLC. The label lists available strengths of 120 mg, 180 mg, 240 mg, 300 mg, 360 mg, and 420 mg. The packaging is a white bottle with a blue cap, featuring a blue and gray label with the product name and dosage form clearly displayed.*

FDA Label Image

A-2 (A 2)

Diltiazem Hydrochloride extended-release tablets in 240 mg strength, manufactured by Slate Run Pharmaceuticals, LLC. The white tablets are round and scored on one side, arranged in a blister pack with individual compartments for each tablet.*

FDA Label Image

A-3 (A 3)

Diltiazem Hydrochloride extended release tablets in a white tablet bottle with a child-resistant cap. The label includes the product name, dosage strength of 60 mg, tablet form, oral route, and manufacturer Slate Run Pharmaceuticals, LLC. The label also features usage and storage instructions along with regulatory text.*

FDA Label Image

A-4 (A 4)

Diltiazem Hydrochloride extended release tablets in 120 mg strength, in a blister pack containing 10 tablets. The packaging is white and blue with a label from Slate Run Pharmaceuticals, LLC. The tablet form and dosage strength are clearly displayed on the pack.*

FDA Label Image

A-5 (A 5)

Diltiazem Hydrochloride 180 mg extended-release tablets bottle label from Slate Run Pharmaceuticals, LLC. The label includes strength, extended-release formulation, oral route, lot number, NDC number, and dispensing information such as "Caution: Federal law prohibits dispensing without a prescription."*

FDA Label Image

A-6 (A 6)

The image shows a rectangular blister card containing 30 extended-release oral tablets of Diltiazem Hydrochloride, 240 mg strength. The card features the Slate Run Pharmaceuticals, LLC label and includes batch and expiry information on the foil backing. Tablets are organized in six rows of five tablets each, and the card is predominantly white with black text and orange accents.*

FDA Label Image

Logo-1 (Logo 1)

Diltiazem Hydrochloride 300 mg extended release oral tablets packaging. The rectangular carton is primarily white with blue and orange design elements. It indicates a 30 count of tablets and is labeled with the labeler name, Slate Run Pharmaceuticals, LLC.*

FDA Label Image

Logo-2 (Logo 2)

Diltiazem Hydrochloride extended release tablets packaging label for 360 mg strength. The label sheet shows multiple tablets aligned in rows on a perforated display card, each tablet individually sealed. The labeler is Slate Run Pharmaceuticals, LLC.*

FDA Label Image

Logo-3 (Logo 3)

Diltiazem Hydrochloride 240 mg extended-release tablets in a white bottle from Slate Run Pharmaceuticals, LLC. The bottle label displays the product name, strength, dosage form, and labeler. The container appears to be a standard prescription pill bottle with a white screw cap.*

FDA Label Image

Logo-4 (Logo 4)

Diltiazem Hydrochloride extended release oral tablets in a prescription bottle. The label shows multiple dosage strengths from 120 mg to 420 mg. The labeler is Slate Run Pharmaceuticals, LLC. The label includes a barcode and standard prescription warnings and information.*

FDA Label Image

Logo-5 (Logo 5)

The image shows a carton of Diltiazem Hydrochloride extended-release tablets, 120 mg strength. The box is primarily white with orange and gray accents and features the Slate Run Pharmaceuticals logo. It indicates oral tablets with an extended-release formulation.*

FDA Label Image

Logo-6 (Logo 6)

Diltiazem Hydrochloride Extended Release tablets in 180 mg strength, oral dosage form. The yellow and pale yellow circular tablets are imprinted with 'U S 522' on one side. Labeler information, Slate Run Pharmaceuticals, LLC, is not visible on the tablets but is part of the product data.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of Diltiazem Hydrochloride showing its molecular components and functional groups, including aromatic rings, oxygen, nitrogen, sulfur atoms, and the hydrochloride component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.